Two Small Caps offering Great Poten ital – Free Analysis Report
The communications company operating globally and posting circa 30% growth in keys business areas. Not only involved in communications and networks, the firm also operates an agri-waste unit that has established landmark projects.
A Pharmaceutical company focussing on the reformulation of generics drugs with trials aiming to penetrate a $4 billion market and a recent tie up with a major global Pharma
Register your interest today:
This Research is a marketing communication. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is also not subject to any prohibition on dealing ahead of the dissemination of investment research, although as a matter of policy Ocean Capital Group requires its employees not to deal ahead of the dissemination of the report.
Ocean Capital Group is a trading name of TS Capital Ltd who is authorised and regulated by the Financial Conduct Authority (FRN: 447281). Registered Office: Ocean Capital Group / TS Capital Ltd, 4th Floor, 6 Lloyds Avenue, London EC3N 3AX
All investments contain an element of risk therefore the value of investments, and the income from them can fall as well as rise, and you may get back less than you invested. An investment’s past performance is not a reliable indicator of future performance. Tax treatment depends on your individual circumstances and may be subject to change in the future. If in any doubt please seek further independent advice.
The information on this site is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.